Concepedia

Author

Jennifer Hodge

Pfizer (United States)

Also Known As

J A Hodge, Jennifer A Hodge, Jennifer A. Hodge, Jennifer Hodge

19

Publications

1.4K

Citations

11

H-Index

11

Concepts

All Affiliations

Pfizer (United States)Oregon Health & Science UniversityCardiff UniversityYale UniversitySeoul National University
JH

About

Jennifer Hodge is an author at Pfizer (United States) specializing in autoimmune disease, rheumatic diseases, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

371

2

Cell Biology

1

1

371

3

Immunology

1

1

371

4

Pharmacology

1

1

371

5

Rheumatology

1

1

371

Jennifer Hodge

×

10

Publications

1.1K

Citations

10

H-Index

YearCitations

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami,

PubMed

2016

371

Regulation of pulmonary fibrosis by chemokine receptor CXCR3

Dianhua Jiang, Jiurong Liang, Jennifer Hodge,

Journal of Clinical Investigation

2004

303

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

Kevin Winthrop, Joel C. Silverfield, Arthur Racewicz,

Annals of the Rheumatic Diseases

2015

193

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

Kevin Winthrop, Ann Wouters, Ernest Choy,

Arthritis & Rheumatology

2017

122

Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis

Ronald van Vollenhoven, Eun Bong Lee, Sander Strengholt,

Arthritis & Rheumatology

2018

50

Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers

Kent J. Weinhold, Jack F. Bukowski, Todd V. Brennan,

Clinical Immunology

2018

30

Regulation of pulmonary fibrosis by chemokine receptor CXCR3

Dianhua Jiang, Jiurong Liang, Jennifer Hodge,

Journal of Clinical Investigation

2004

22

Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life Products.

Amit Chhabra, Patrick Fogarty, Bartholomew J. Tortella,

PubMed

2018

19

Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects

Barbara Finck, Helen Tang, Francesca Civoli,

Advances in Therapy

2020

18

Impact of Contextual Factors on Interventions to Reduce Acute Care Transfers II Implementation and Hospital Readmission Rates

Kimberly J. Rask, Jennifer Hodge, Linda Kluge

Journal of the American Medical Directors Association

2017

10

Page 1